Page |
||||
F-2 |
||||
F-4 |
||||
F-5 |
||||
F-6 |
||||
F-7 |
||||
F- 8 |
Mago Inc. Page 2 |
Note |
December 31, 2021 |
December 31, 2020 |
||||||||
Assets |
||||||||||
Cash and cash equivalent |
||||||||||
Digital assets |
7 | |||||||||
Loans receivable |
4 | |||||||||
Prepaid expenses, and other receivables and assets |
5 |
|||||||||
Investment portfolio |
8, 26 | |||||||||
Investment accounted for using the equity method |
25 | |||||||||
Property and equipment |
9 | |||||||||
Right-of-use |
12 |
|||||||||
Intangible assets |
10 | |||||||||
Derivative financial assets |
25 | |||||||||
Goodwill |
24 | |||||||||
|
|
|
|
|||||||
Total assets |
||||||||||
|
|
|
|
|||||||
Liabilities |
||||||||||
Accounts payable, accruals and other |
11 |
|||||||||
Lease liabilities |
1 2 |
|||||||||
Credit facilities |
13 | |||||||||
Debentures |
14 | |||||||||
Convertible debentures |
15 | |||||||||
Derivative financial liabilities |
16 | |||||||||
Deferred tax liability |
||||||||||
|
|
|
|
|||||||
Total liabilities |
||||||||||
|
|
|
|
|||||||
Shareholders’ Equity |
||||||||||
Share capital |
28a | |||||||||
Contributed surplus |
||||||||||
Revaluation reserve |
7 | |||||||||
Foreign currency translation reserve |
||||||||||
Deficit |
( |
) | ( |
) | ||||||
|
|
|
|
|||||||
Total shareholders’ equity |
||||||||||
|
|
|
|
|||||||
Total equity and liabilities |
||||||||||
|
|
|
|
For the years ended |
||||||||||||
Note |
December 31, 2021 |
December 31, 2020 |
||||||||||
Revenue |
||||||||||||
Subscription and services |
||||||||||||
Interest revenue |
||||||||||||
|
|
|
|
|||||||||
18 | ||||||||||||
|
|
|
|
|||||||||
Cost of revenue |
||||||||||||
Provision for loan losses, net of recoveries |
4 | |||||||||||
Transaction costs |
||||||||||||
|
|
|
|
|||||||||
|
|
|
|
|||||||||
Gross profit |
||||||||||||
|
|
|
|
|||||||||
Operating expenses |
||||||||||||
Technology and development |
||||||||||||
Marketing |
||||||||||||
Customer service and operations |
||||||||||||
General and administration |
||||||||||||
Stock-based compensation |
||||||||||||
Depreciation and amortization |
9,10,12 | |||||||||||
|
|
|
|
|||||||||
Total operating expenses |
19 | |||||||||||
|
|
|
|
|||||||||
(Loss) income from operations |
( |
) |
||||||||||
|
|
|
|
|||||||||
Other expenses (income) |
||||||||||||
Credit facility interest expense |
13 | |||||||||||
Debenture and other financing expense |
6,14,15 | |||||||||||
Accretion related to debentures and convertible debentures |
|
|
14,15 |
|
|
|
|
|
|
|
|
|
Share of loss in investment accounted for using the equity method |
25 | |||||||||||
Revaluation (gains) losses |
20 | ( |
) |
|||||||||
Other non-operating expenses (income) |
21 | ( |
) | |||||||||
|
|
|
|
|||||||||
( |
) | |||||||||||
|
|
|
|
|||||||||
Net loss before tax |
( |
) | ( |
) | ||||||||
|
|
|
|
|||||||||
Income tax recovery |
17 | ( |
) |
|||||||||
|
|
|
|
|||||||||
Net loss |
( |
) | ( |
) | ||||||||
|
|
|
|
|||||||||
Other comprehensive income: |
||||||||||||
Items that will not be reclassified subsequently to profit or loss: |
||||||||||||
Unrealized revaluation gain on digital assets |
7 | |||||||||||
Items that are or may be reclassified subsequently to profit or loss: |
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency translation reserve gain |
||||||||||||
|
|
|
|
|||||||||
Other comprehensive income |
||||||||||||
|
|
|
|
|||||||||
Total comprehensive loss |
( |
) | ( |
) | ||||||||
Net loss per share |
|
|
21 |
|
|
|
|
|
|
|
|
|
Basic loss per share |
( |
) | ( |
) | ||||||||
Diluted loss per share |
( |
) | ( |
) | ||||||||
Weighted average number of basic common shares (in 000s) |
||||||||||||
Weighted average number of fully diluted common shares (in 000s) |
||||||||||||
|
|
|
|
Number of shares (000s) |
Share capital |
Contributed surplus |
Foreign currency translation reserve |
Revaluation reserve |
Deficit |
Total |
||||||||||||||||||||||||||
Balance, December 31, 2020 |
$ |
$ |
$ |
— |
$ |
— |
$ |
( |
) |
$ |
||||||||||||||||||||||
Net loss | — | — | — | — | — | ( |
) | ( |
) | |||||||||||||||||||||||
Treasury shares reserve (Note 28b) | ( |
) | ( |
) | — | — | — | — | ( |
) | ||||||||||||||||||||||
Foreign currency translation reserve | — | — | — | |
— | — | ||||||||||||||||||||||||||
Revaluation reserve (Note 7) | — | — | — | — | |
— | ||||||||||||||||||||||||||
Stock-based compensation (Note 28c) | — | — | — | — | — | |||||||||||||||||||||||||||
Options and restricted share units (“ RSUs |
( |
) | — | — | — | |||||||||||||||||||||||||||
Shares issued – ATM arrangement, net | — | — | — | — | ||||||||||||||||||||||||||||
Shares issued – Registered direct offerings | — | — | — |
|||||||||||||||||||||||||||||
Shares issued on acquisition of Carta (Note 24) | — | — | — | — | ||||||||||||||||||||||||||||
Shares issued on acquisition of Moka (Note 24) | — | — | — | — | ||||||||||||||||||||||||||||
Shares issued - replacement awards (Note 24) |
|
|
|
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
Shares issued on acquisition of Fortification (Note 24) | — | — | — | — | ||||||||||||||||||||||||||||
Shares issued for purchase of investment accounted for using the equity method (Note 25) | — | — | — | — | ||||||||||||||||||||||||||||
Shares issued – convertible debentures (Note 15) | — | — | — | — | ||||||||||||||||||||||||||||
Equity settled share based payment | — | — | — | — | ||||||||||||||||||||||||||||
Warrants issued for broker services (Note 28e) | — | — | — | — | — | |||||||||||||||||||||||||||
Warrants exercised (Note 28e) | ( |
) | — | — | — | |||||||||||||||||||||||||||
Amortization of warrants (Note 28e) | — | — | — | — | — | |||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Balance, December 31, 2021 |
( |
) | ||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares (000s) |
Share capital |
Contributed surplus |
Deficit |
Total |
||||||||||||||||||||
Balance, December 31, 2019 |
$ |
$ |
$ |
( |
) |
$ |
||||||||||||||||||
Net loss |
— | — | — | ( |
) | ( |
) | |||||||||||||||||
Stock-based compensation (Note 28c) |
— | — | — | |||||||||||||||||||||
Options and restricted share units (“ RSUs |
( |
) | — | |||||||||||||||||||||
Shares issued – debentures |
— | — | ||||||||||||||||||||||
Equity portion – convertible debentures (Note 15) |
— | — | — | |||||||||||||||||||||
Shares issued – convertible debentures (Note 15) |
— | — | ||||||||||||||||||||||
Shares issued – Partial settlement of credit facility prepayment |
— | — | ||||||||||||||||||||||
Shares issued to settle debt |
— | — | ||||||||||||||||||||||
Warrants issued (Note 28e) |
— | — | — | |||||||||||||||||||||
Conversion of warrants (Note 28e) |
( |
) | — | |||||||||||||||||||||
Amortization of warrants (Note 28e) |
— | — | — | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance, December 31, 2020 |
( |
) |
||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
Year ended |
||||||||||||
Note |
December 31, 2021 |
December 31, 2020 |
||||||||||
Cash provided by (used in) the following activities: |
||||||||||||
Operating activities |
||||||||||||
Net loss |
( |
) | ( |
) | ||||||||
Items not affecting cash: |
||||||||||||
Depreciation and amortization |
||||||||||||
Postmedia warrant expenses |
28e | |||||||||||
Provision for loan losses |
4 | |||||||||||
Credit facility and debenture interest expense |
||||||||||||
Accretion related to debentures and convertible debentures |
||||||||||||
Share of loss from investment in associate |
25 | |||||||||||
Stock-based compensation expense |
28c | |||||||||||
Revaluation (gains) losses |
20 | ( |
) |
|||||||||
Other non-operating (income) expenses |
( |
) | ||||||||||
Income tax recovery on deferred tax liability |
( |
) |
||||||||||
|
|
|
|
|||||||||
( |
) |
|||||||||||
Changes in: |
||||||||||||
Net issuance of loans receivable |
( |
) |
||||||||||
Proceeds from sale of loan book |
||||||||||||
Prepaid expenses, deposits and other assets |
5 | ( |
) |
|||||||||
Accounts payable and accruals |
11 | ( |
) | |||||||||
|
|
|
|
|||||||||
Cash (used in) generated from operating activities |
( |
) |
||||||||||
Interest paid |
( |
) |
( |
) | ||||||||
|
|
|
|
|||||||||
Net cash (used in) generated from operating activities |
( |
) |
||||||||||
|
|
|
|
|||||||||
Investing activities |
||||||||||||
Acquisition of a subsidiary, net of cash acquired |
||||||||||||
Proceeds from sale of investment |
||||||||||||
Cash invested in investment portfolio |
( |
) |
( |
) | ||||||||
Cash invested in investment accounted for using the equity method |
25 | ( |
) |
|||||||||
Purchases of property and equipment |
( |
) |
( |
) | ||||||||
Investment in digital assets |
7 | ( |
) |
|||||||||
Investment in intangible assets |
( |
) |
( |
) | ||||||||
|
|
|
|
|||||||||
Net cash used in investing activities |
( |
) |
( |
) | ||||||||
|
|
|
|
|||||||||
Financing activities |
||||||||||||
Lease liabilities – principal payments |
12 | ( |
) |
( |
) | |||||||
R epayments on debentures |
( |
) |
( |
) | ||||||||
A dvance (repayments) on credit facilities |
( |
) | ||||||||||
Proceeds from issuance of common shares, net of transaction costs |
||||||||||||
Proceeds from exercise of warrants |
||||||||||||
Proceeds from exercise of options |
||||||||||||
|
|
|
|
|||||||||
Net cash provided by (used in) financing activities |
( |
) | ||||||||||
|
|
|
|
|||||||||
Net increase in cash |
||||||||||||
Effect of exchange rate fluctuations |
||||||||||||
Cash and cash equivalent, beginning of period |
||||||||||||
|
|
|
|
|||||||||
Cash and cash equivalent, end of period |
||||||||||||
|
|
|
|
1. |
Nature of operations |
2. |
Basis of presentation (Continued from previous page) |
2. |
Basis of presentation (Continued from previous page) |
☐ | The Company has power over the entity whereby the Company has the ability to direct the relevant activities (i.e., the activities that affect the entity’s returns); |
☐ | The Company is exposed, or has rights, to variable returns from its involvement with the entity; and |
☐ | The Company has the ability to use its power over the entity to affect the amount of the entity’s returns. |
3. |
Significant accounting policies |
(a) |
Revenue recognition |
3. |
Significant accounting policies (Continued from previous page) |
(a) |
Revenue recognition (Continued from previous page) |
(b) |
Cost of revenue |
3. |
Significant accounting policies (Continued from previous page) |
(c) |
Financial instruments |
☐ | it is held within a business model whose objective is to hold assets to collect contractual cash flows; and |
☐ | its contractual terms give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding. |
☐ | it is held within a business model whose objective is achieved by both collecting contractual cash flows and selling financial assets; and |
☐ | its contractual terms give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding. |
3. |
Significant accounting policies (Continued from previous page) |
(c) |
Financial instruments (Continued from previous page) |
3. |
Significant accounting policies (Continued from previous page) |
(c) |
Financial instruments (Continued from previous page) |
(d) |
Property and equipment |
|
||||
Rate |
||||
|
||||
Computer equipment |
% | |||
Furniture and fixtures |
% | |||
Leasehold improvements | ||||
|
3. |
Significant accounting policies (Continued from previous page) |
(e) |
Intangible assets |
Rate | ||
Software - Internally generated |
||
Software licenses |
||
Technology assets - Acquired |
||
Customer relationships |
||
Regulatory licenses |
||
Brand and trade name |
☐ | the technical feasibility of completing the intangible asset so that it will be available for use or sale; |
☐ | its intention to complete and its ability to use or sell the asset; |
☐ | how the asset will generate future economic benefits; |
☐ | the availability of resources to complete the asset; and |
☐ | the ability to measure reliably the expenditure during development. |
(f) |
Goodwill |
3. |
Significant accounting policies (Continued from previous page) |
(g) |
Impairment of non-financial assets |
☐ | Carta; and |
☐ | Remaining Mogo related entities. |
(h) |
Digital assets |
3. |
Significant accounting policies (Continued from previous page) |
(h) |
Digital assets (Continued from previous page) |
(i) |
Foreign currency translation |
(j) |
Foreign operations |
(k) |
Provisions |
(l) |
Income taxes |
(m) |
Investment tax credits |
3. |
Significant accounting policies (Continued from previous page) |
(n) |
Sales tax |
(o) |
Share-based payments |
(p) |
Earnings per share |
(q) |
Business combinations |
3. |
Significant accounting policies (Continued from previous page) |
(r) |
Investment in associate |
(s) |
Cash and cash equivalent |
(t) |
Leases |
3. |
Significant accounting policies (Continued from previous page) |
(t) |
Leases (Continued from previous page) |
(u) |
Government assistance |
(v) |
Significant accounting judgements, estimates and assumptions |
3. |
Significant accounting policies (Continued from previous page) |
(v) |
Significant accounting judgements, estimates and assumptions (Continued from previous page) |
(i) |
Allowance for loan losses |
(ii) |
Fair value of privately held investments |
(iii) |
Fair value of identifiable intangible assets acquired from business combinations |
(iv) |
Valuation of goodwill acquired in business combinations |
(w) |
New and amended standards and interpretations |
3. |
Significant accounting policies (Continued from previous page) |
(w) |
New and amended standards and interpretations (Continued from previous page) |
4. |
Loans receivable |
December 31, 2021 |
December 31, 2020 |
|||||||
Current (terms of one year or less) |
||||||||
Non-current (terms exceeding one year) |
||||||||
4. |
Loans receivable (Continued from previous page) |
As at December 31, 2021 |
||||||||||||||||||
Risk Category |
Days past due |
Stage 1 |
Stage 2 |
Stage 3 |
Total |
|||||||||||||
Strong |
— | — | ||||||||||||||||
Lower risk |
— | — | ||||||||||||||||
Medium risk |
— | — | ||||||||||||||||
Higher risk |
— | — | ||||||||||||||||
Non-performing |
bankrupt |
— | — | |||||||||||||||
Gross loans receivable | ||||||||||||||||||
Allowance for loan losses | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||
Loans receivable, net |
||||||||||||||||||
As at December 31, 2020 |
||||||||||||||||||
Risk Category |
Days past due |
Stage 1 |
Stage 2 |
Stage 3 |
Total |
|||||||||||||
Strong |
— | — | ||||||||||||||||
Lower risk |
— | — | ||||||||||||||||
Medium risk |
— | — | ||||||||||||||||
Higher risk |
— | — | ||||||||||||||||
Non-performing |
bankrupt |
— | — | |||||||||||||||
Gross loans receivable | ||||||||||||||||||
Allowance for loan losses | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||
Loans receivable, net |
||||||||||||||||||
4. |
Loans receivable (Continued from previous page) |
As at December 31, 2021 |
||||||||||||||||
Stage 1 |
Stage 2 |
Stage 3 |
Total |
|||||||||||||
Balance as at January 1, 2021 |
||||||||||||||||
Gross loans originated |
— | — | ||||||||||||||
Principal payments |
( |
) | ( |
) | ( |
) | ||||||||||
Re-measurement of allowance before transfers |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Re-measurement of amounts transferred between stages |
( |
) | ||||||||||||||
Transfer to (from) |
||||||||||||||||
Stage 1 – 12 month ECLs |
( |
) | ( |
) | — | |||||||||||
Stage 2 – Lifetime ECLs |
( |
) | — | |||||||||||||
Stage 3 – Lifetime ECLs |
( |
) | ( |
) | — | |||||||||||
Net amounts written off against allowance |
— | — | ( |
) | ( |
) | ||||||||||
Balance as at December 31, 2021 |
||||||||||||||||
As at December 31, 2020 |
||||||||||||||||
Stage 1 |
Stage 2 |
Stage 3 |
Total |
|||||||||||||
Balance as at January 1, 2020 |
||||||||||||||||
Gross loans originated |
— | — | ||||||||||||||
Principal payments |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Derecognition of allowance associated with Liquid Sale |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Re-measurement of allowance before transfers |
||||||||||||||||
Re-measurement of amounts transferred between stages |
( |
) | ||||||||||||||
Transfer to (from) |
||||||||||||||||
Stage 1 – 12 month ECLs |
( |
) | ( |
) | — | |||||||||||
Stage 2 – Lifetime ECLs |
( |
) | ( |
) | — | |||||||||||
Stage 3 – Lifetime ECLs |
( |
) | ( |
) | — | |||||||||||
Net amounts written off against allowance |
— | — | ( |
) | ( |
) | ||||||||||
Balance as at December 31, 2020 |
||||||||||||||||
4. |
Loans receivable (Continued from previous page) |
Allowance for loan losses |
Year ended |
|||||||
December 31, 2021 |
December 31, 2020 |
|||||||
Balance, beginning of period |
||||||||
Derecognition of allowance associated with loan sale |
— |
( |
) | |||||
Provision for loan losses |
||||||||
Charge offs |
( |
) |
( |
) | ||||
|
|
|
|
|||||
Balance, end of period |
||||||||
|
|
|
|
5. |
Prepaid expenses, deposits and other assets |
December 31, 2021 |
December 31, 2020 |
|||||||
Prepaid expenses |
||||||||
Accounts receivabl e |
|
|
|
|
|
|
|
|
Brokerage firm receivables |
|
|
|
|
|
|
|
|
Deposits and other receivables |
||||||||
|
|
|
|
|||||
|
|
|
|
6. |
Related party transactions |
2021 |
2020 | |||||||
Salary and short – term benefits |
|
|
|
|
|
|
|
|
Share – based payments |
||||||||
|
|
|
|
|||||
|
|
|
|
7. |
Digital assets |
Quantities |
Average cost per unit |
Fair value per unit |
Total fair value ($000s) |
Historical cost ($000s) |
Cumulative revaluation gain (loss) ($000s) |
|||||||||||||||||||
Bitcoin (BTC) |
$ | $ | $ | $ | $ | |||||||||||||||||||
Ethereum (ETH) |
||||||||||||||||||||||||
|
|
|
|
|
|
|||||||||||||||||||
|
|
|
|
|
|
8. |
Investment portfolio |
December 31, 2021 |
December 31, 2020 |
|||||||
Equities |
||||||||
Other |
||||||||
|
|
|
|
|||||
|
|
|
|
9. |
Property and equipment |
Computer equipment |
Furniture and fixtures |
Leasehold improvements |
Total |
|||||||||||||
Cost |
||||||||||||||||
Balance, December 31, 2019 |
||||||||||||||||
Additions |
— | — | ||||||||||||||
Disposals |
( |
) | — | ( |
) | ( |
) | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Balance, December 31, 2020 |
||||||||||||||||
Additions |
— | |||||||||||||||
Additions through business combinations |
— | |||||||||||||||
Effects of movement in exchange rate |
( |
) | ( |
) | — | ( |
) | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Balance, December 31, 2021 |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Accumulated depreciation |
||||||||||||||||
Balance, December 31, 2019 |
||||||||||||||||
Depreciation |
||||||||||||||||
Disposals |
( |
) | — | ( |
) | ( |
) | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Balance, December 31, 2020 |
||||||||||||||||
Depreciation |
— | |||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Balance, December 31, 2021 |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net book value |
||||||||||||||||
Balance, December 31, 2020 |
— | |||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Balance, December 31, 2021 |
— |
|||||||||||||||
|
|
|
|
|
|
|
|
10. |
Intangible assets |
Internally generated – completed |
Internally generated – in progress |
Software licenses |
Acquired technology assets |
Customer relationships |
Brand |
Regulatory licenses |
Total |
|||||||||||||||||||||||||
Cost |
||||||||||||||||||||||||||||||||
Balance, December 31, 2019 |
— | — | — | — | ||||||||||||||||||||||||||||
Additions |
— | — | — | — | — | — | ||||||||||||||||||||||||||
Transfers |
( |
) | — | — | — | — | — | — | ||||||||||||||||||||||||
Balance, December 31, 2020 |
||||||||||||||||||||||||||||||||
Additions |
— | — | — | — | — | |||||||||||||||||||||||||||
Additions through a business combination |
— | — | ||||||||||||||||||||||||||||||
Impairment |
— | ( |
) | — | — | — | — | — | ( |
) | ||||||||||||||||||||||
Transfers |
( |
) | — | — | — | — | — | — | ||||||||||||||||||||||||
Effects of movement in exchange rate |
— | — | ( |
) | — | — | — | — | ( |
) | ||||||||||||||||||||||
Balance, December 31, 2021 |
||||||||||||||||||||||||||||||||
Accumulated depreciation |
||||||||||||||||||||||||||||||||
Balance, December 31, 2019 |
— | — | — | — | — | |||||||||||||||||||||||||||
Amortization |
— | — | — | — | — | |||||||||||||||||||||||||||
Balance, December 31, 2020 |
— | — | ||||||||||||||||||||||||||||||
Amortization |
— | — | ||||||||||||||||||||||||||||||
Balance, December 31, 2021 |
— |
— |
||||||||||||||||||||||||||||||
Net book value |
||||||||||||||||||||||||||||||||
Balance, December 31, 2020 |
— | — | — | — | ||||||||||||||||||||||||||||
Balance, December 31, 2021 |
||||||||||||||||||||||||||||||||
11. |
Accounts payable and accruals |
December 31, 2021 |
December 31, 2020 |
|||||||
Accounts payables |
||||||||
Accrued expenses |
||||||||
Accrued wages and other benefits |
||||||||
Client liabilities |
||||||||
Others |
||||||||
12. |
Leases |
Right -of-use- assets |
Lease Liabilities |
|||||||
As at January 1, 2020 |
||||||||
Modifications and renewals |
( |
) | ||||||
Additions |
( |
) | ( |
) | ||||
Depreciation expense |
( |
) | — | |||||
Interest expense |
— | |||||||
Payments |
— | ( |
) | |||||
As at December 31, 2020 |
||||||||
Additions |
||||||||
Disposals |
( |
) | ( |
) | ||||
Depreciation expense |
( |
) | — | |||||
Interest expense |
— | |||||||
Payments |
— | ( |
) | |||||
As at December 31, 2021 |
||||||||
12. |
Leases (Continued from previous page) |
2021 |
2020 |
|||||||
Depreciation expense of right-of-use |
|
|
||||||
Interest expense on lease liabilities |
||||||||
Expenses relating to short term leases |
||||||||
Variable lease payments |
||||||||
|
|
|
|
|||||
Total amount recognized in consolidated statement of operations and comprehensive loss |
||||||||
|
|
|
|
13. |
Credit facilities |
13. |
Credit facilities (Continued from previous page) |
December 31, 2021 |
December 31, 2020 |
|||||||
|
|
|
|
|||||
Credit facility |
||||||||
Funds drawn |
||||||||
|
|
|
|
|||||
|
|
|
|
14. |
Debentures |
i) | a reduction in the weighted average coupon interest rate, from approximately |
ii) | replacement of the former monthly interest payable by a new quarterly payment (the “ Quarterly Payment |
iii) | settlement of the new Quarterly Payment on the first business day following the end of a calendar quarter at the Company’s option either in cash or Common Shares; and |
iv) | an option for all debenture holders to receive a lump-sum payout of their previously unpaid interest for the period from |
14. |
Debentures (Continued from previous page) |
December 31, 2021 |
December 31, 2020 |
|||||||
|
|
|
|
|||||
Principal balance |
||||||||
Discount |
( |
) |
( |
) | ||||
|
|
|
|
|||||
Interest payable |
||||||||
|
|
|
|
|||||
|
|
|
|
14. |
Debentures (Continued from previous page) |
Principal component of quarterly payment |
Principal due on maturity |
Total |
||||||||||
2022 |
— | |||||||||||
2023 |
||||||||||||
2024 |
||||||||||||
|
|
|
|
|
|
|||||||
|
|
|
|
|
|
15. |
Convertible debentures |
15. |
Convertible debentures (Continued from previous page) |
Net book value, December 31, 2021 |
Net book value, December 31, 2020 |
|||||||
Convertible debentures |
||||||||
Transaction costs |
— |
( |
) | |||||
|
|
|
|
|||||
Net proceeds |
||||||||
|
|
|
|
|||||
Conversion of debentures to equity |
( |
) |
( |
) | ||||
Accretion in carrying value of debenture liability |
— |
|||||||
Accrued interest |
||||||||
Interest converted in shares and paid |
( |
) |
( |
) | ||||
|
|
|
|
|||||
|
|
|
|
16. |
Derivative financial liabilities |
16. |
Derivative financial liabilities (Continued from previous page) |
December 31, 2021 |
December 31, 2020 |
|||||||
Balance, December 31, 2020 |
||||||||
Stock warrants issued |
||||||||
Change in fair value due to revaluation of derivative financial liabilities |
( |
) |
||||||
Change in fair value due to foreign exchange |
( |
) |
||||||
|
|
|
|
|||||
Balance, December 31, 2021 |
||||||||
|
|
|
|
Warrants Outstanding and exercisable (000s) |
Weighted Average Exercise Price $ |
|||||||
Balance, December 31, 2020 |
||||||||
Warrants granted |
||||||||
|
|
|
|
|||||
Balance, December 31, 2021 |
||||||||
|
|
|
|
As at December 31, 2021 |
As at December 31, 2020 |
|||||||
Risk-free interest rate |
||||||||
Expected life |
||||||||
Expected volatility in market price of shares |
||||||||
Expected dividend yield |
||||||||
Expected forfeiture rate |
|
|||||||
|
|
|
|
17. |
Income taxes |
(a) | Provision for income taxes |
2021 |
2020 | |||||||
Current tax expense |
||||||||
Deferred tax recovery |
( |
) | ||||||
Income tax recovery |
|
|
( |
) |
|
|
|
|
|
|
|
|
2021 |
2020 | |||||||
Canadian federal and provincial recovery of income taxes using statutory rate of 27% (2020 – 27%) |
( |
) |
( |
) | ||||
Change in unrecognized deductible temporary differences and unused tax losses |
||||||||
Permanent differences and other |
||||||||
|
|
|
|
|||||
Income tax recover y |
( |
) |
||||||
|
|
|
|
(b) | Deferred tax assets |
2021 |
2020 | |||||||
Non-capital losses |
|
|||||||
Property and equipment |
|
|
|
|
|
|
|
|
Intangible assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(c) | Deferred tax liabilities |
2021 |
2020 | |||||||
Intangible assets |
2 |
|||||||
Digital assets and derivatives |
||||||||
Equity investments |
|
|
|
|
|
|
|
|
Deferred cos t |
||||||||
|
|
|
|
|||||
|
|
|
|
17. |
Income taxes (Continued from previous page) |
(d) | Deductible temporary differences and unused tax losses |
2021 |
2020 | |||||||
Unused tax losses |
|
|
|
|
|
|
| |
Property and equipment |
||||||||
Right-of-use |
||||||||
Intangible assets |
||||||||
Debentures |
||||||||
Convertible debentures |
||||||||
Financing costs |
||||||||
Research and development expenditures |
||||||||
Investment in subsidiaries |
|
|
|
|
|
|
| |
Other |
||||||||
|
|
|
|
|||||
|
|
|
|
17. |
Income taxes (Continued from previous page) |
2021 |
2020 |
|||||||
Expires 2024 |
||||||||
Expires 2025 |
||||||||
Expires 2026 |
||||||||
Expires 2027 |
6,8 8 5 |
|||||||
Expires 2028 |
||||||||
Expires 2029 |
||||||||
Expires 2030 |
||||||||
Expires 2031 |
||||||||
Expires 2032 |
||||||||
Expires 2033 |
||||||||
Expires 2034 |
||||||||
Expires 2035 |
||||||||
Expires 2036 |
||||||||
Expires 2037 |
||||||||
Expires 2038 |
||||||||
Expires 2039 |
||||||||
Expires 2040 |
||||||||
Expires 2041 |
|
|
|
|
|
|
— | |
|
|
|
|
|||||
|
|
|
|
18. |
Geographic information |
(a) | Revenue |
Year ended |
||||||||
December 31, 2021 |
December 31, 2020 |
|||||||
Canada |
||||||||
Europe |
— | |||||||
Other |
— | |||||||
|
|
|
|
|||||
Total |
||||||||
|
|
|
|
18. |
Geographic information (Continued from previous page) |
(b) | Non-current assets |
Year ended |
||||||||
December 31, 2021 |
December 31, 2020 |
|||||||
Canada |
||||||||
Europe |
— | |||||||
Other |
— | |||||||
|
|
|
|
|||||
Total |
||||||||
|
|
|
|
19. |
Expenses by nature and function |
2021 |
2020 | |||||||
Personnel expense |
||||||||
Marketing |
||||||||
Depreciation and amortization |
||||||||
Stock-based compensation |
||||||||
Hosting and software licenses |
||||||||
Professional services |
||||||||
Insurance and licenses |
||||||||
Credit verification costs |
||||||||
Premises |
||||||||
Others |
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
|
For the years ended |
||||||||
December 31, 2021 |
December 31, 2020 |
|||||||
Technology and development |
||||||||
Marketing |
||||||||
Customer service and operations |
||||||||
General and administration |
||||||||
|
|
|
|
|||||
Total operating expenses |
||||||||
|
|
|
|
20. |
Revaluation (gains) and losses |
Year ended |
||||||||
December 31, 2021 |
December 31, 2020 |
|||||||
Change in fair value due to revaluation of derivative financial asset |
( |
) |
— | |||||
Change in fair value due to revaluation of derivative financial liabilities |
( |
) |
8 |
|||||
Realized gain on investment portfolio |
( |
) | — | |||||
Unrealized loss on investment portfolio |
||||||||
Unrealized exchange loss |
||||||||
Unrealized gain on other receivable |
— |
( |
) | |||||
Losses related to property and equipment |
— |
|||||||
|
|
|
|
|||||
( |
) |
|||||||
|
|
|
|
21. |
Other non-operating (income) expenses |
Year ended |
||||||||
December 31, 2021 |
December 31, 2020 |
|||||||
Gain on sale of loan book |
— |
( |
) | |||||
Credit facility prepayment and related expenses |
— |
|||||||
Convertible debenture early conversion |
— |
|||||||
Gain on amendment of debentures |
— |
( |
) | |||||
Government grants |
( |
) |
( |
) | ||||
Direct offering transaction costs allocated to derivative financial liabilities |
— | |||||||
Acquisition costs, restructuring and other |
||||||||
|
|
|
|
|||||
( |
) | |||||||
|
|
|
|
21. |
Other non-operating (income) expenses (Continued from previous page) |
22. |
Loss per share |
2021 |
2020 | |||||||
Loss attributed to shareholders |
( |
) | ( |
) | ||||
Basic weighted average number of shares (in 000s) |
||||||||
Basic and diluted loss per share |
( |
) |
( |
) | ||||
|
|
|
|
23. |
Capital management |
2021 |
2020 | |||||||
Share capital |
||||||||
Deficit |
( |
) | ( |
) | ||||
Credit facilities |
||||||||
Debentures |
||||||||
Convertible debentures |
— |
23. |
Capital management (Continued from previous page) |
24. |
Business combination |
24. |
Business combination (Continued from previous page) |
January 25, 2021 |
||||
Assets acquired: |
||||
Cash and cash equivalent |
||||
Prepaids, and other receivables and assets |
||||
Property and equipment |
||||
Right-of-use |
||||
Intangible assets - technology assets |
||||
I ntangible assets - customer relationships |
||||
Intangible assets - software licenses |
||||
Intangible assets - brand |
||||
Goodwill |
||||
Liabilities assumed: |
||||
Accounts payable, accruals & other |
||||
Lease liabilities |
||||
Net assets acquired at fair value |
||||
Share consideration |
||||
24. |
Business combination (Continued from previous page) |
May 4, 2021 |
||||
Assets acquired: |
||||
Cash and cash equivalent |
||||
Prepaids, and other receivables and assets |
||||
Property and equipment |
||||
Intangible assets - technology assets |
||||
Intangible assets - customer relationships |
||||
Intangible assets - regulatory licenses |
||||
Goodwill |
||||
Liabilities assumed: |
||||
Accounts payable, accruals & other |
||||
Deferred tax liabilities |
||||
Net assets acquired at fair value |
||||
Share consideration |
||||
Cash consideration |
||||
Total consideration transferred |
||||
24. |
Business combination (Continued from previous page) |
September 1, 2021 |
||||
Assets acquired: |
||||
Cash and cash equivalent |
||||
Prepaids, and other receivables and assets |
||||
Intangible assets - regulatory licenses |
||||
Goodwill |
||||
Liabilities assumed: |
||||
Accounts payable, accruals & other |
||||
Deferred tax liabilities |
||||
Net assets acquired at fair value |
||||
Share consideration |
||||
Cash consideration |
||||
Total consideration transferred |
||||
25. |
Investment accounted for using the equity method |
☐ | a right for Mogo to purchase Call Option |
☐ | a right for these certain selling shareholders to require Mogo to purchase Put Option . |
☐ | the issuance of a warrant to Mogo to acquire Coinsquare Warrant |
☐ | the exercise of the Call Option, to acquire . |
☐ | the purchase of Common Shares that were issued in three equal tranches on June 4, July 4 and August 4, 2021 respectively. |
25. |
Investment accounted for using the equity method (Continued from previous page) |
Initial recognition date |
Initial fair value on recognition |
Call/Put Option fair value at exercise |
Value at December 31, 2021 |
Revaluation (gains) losses |
||||||||||||||||
Initial 19.99% investment |
n/a | — | ||||||||||||||||||
Call Option |
— | ( |
) | |||||||||||||||||
Put Option |
( |
) | — | — | ( |
) | ||||||||||||||
Coinsquare Warrants |
n/a | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total - Initial Transaction |
( |
) | ||||||||||||||||||
New Call Option |
n/a |
— | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total revaluation gains |
( |
) | ||||||||||||||||||
|
|
As at December 31, 2021 |
||||
Risk-free interest rate |
||||
Expected life |
||||
Expected volatility in market price of shares |
||||
Expected dividend yield |
||||
Expected forfeiture rate |
||||
|
|
25. |
Investment accounted for using the equity method (Continued from previous page) |
As at December 31, 2021 |
||||
|
||||
Current assets |
||||
Non-current assets |
||||
Current liabilities |
( |
) | ||
Non-current liabilities |
( |
) | ||
|
|
|||
Net assets |
||||
|
|
|||
Company’s share of net assets - |
||||
Intangible assets |
||||
Deferred tax liabilities |
|
|
( |
) |
Goodwill |
||||
|
|
|||
Carrying amount of interest in associate |
||||
|
|
April 16, 2021 to December 31, 2021 |
||||
|
||||
Revenue |
||||
Net income from continuing operations (100%) |
||||
Post-tax loss from discontinued operations (100%) |
( |
) | ||
Other comprehensive loss (100%) |
( |
) | ||
|
|
|||
Total comprehensive income (100%) |
||||
Company’s share of total comprehensive loss |
( |
) | ||
|
|
|||
Initial investment in Coinsquare |
||||
Step up investments in Coinsquare |
||||
|
|
|||
Total investments in Coinsquare |
||||
Share of loss in associate |
( |
) | ||
|
|
|||
Carrying amount of equity accounted investment |
||||
|
|
|||
Mogo’s share of: |
||||
Net income from continuing operations |
||||
Post-tax loss from discontinued operations |
( |
) | ||
Other comprehensive income |
( |
) | ||
Amortization of intangible assets |
( |
) | ||
Amortization of deferred tax liabilities |
|
|
|
|
|
|
|||
Total other comprehensive loss |
( |
) | ||
|
|
26. |
Fair value of financial instruments |
☐ | Level 1: Unadjusted quoted prices in an active market for identical assets and liabilities. |
☐ | Level 2: Quoted prices in markets that are not active or inputs that are derived from quoted prices of similar (but not identical) assets or liabilities in active markets. |
☐ | Level 3: Unobservable inputs that are supported by little or no market activity and are significant to the estimated fair value of the assets or liabilities. |
(a) | Valuation process |
26. |
Fair value of financial instruments (Continued from previous page) |
(b) | Accounting classifications and fair values |
Carrying amount |
Fair value |
|||||||||||||||||||||||||||||||||||
December 31, 2021 |
Note |
Mandatorily at FVTPL |
Financial asset at amortized cost |
Other financial liabilities |
Total |
Level 1 |
Level 2 |
Level 3 |
Total |
|||||||||||||||||||||||||||
Financial assets measured at fair value |
||||||||||||||||||||||||||||||||||||
Investment portfolio | — | — | — | |||||||||||||||||||||||||||||||||
Derivative financial assets | 25 | — | — | — | — | |||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||
— |
— |
|||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||
Financial assets not measured at fair value |
||||||||||||||||||||||||||||||||||||
Cash and cash equivalent | — | — | — | — | ||||||||||||||||||||||||||||||||
Loans receivable – current | 4 | — | — | — | — | |||||||||||||||||||||||||||||||
Loans receivable – non-current |
4 | — | — | — | — | |||||||||||||||||||||||||||||||
Other receivables | — | — | — | — | ||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||
— |
— |
|||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||
Financial liabilities measured at fair value |
||||||||||||||||||||||||||||||||||||
Derivative financial liabilities |
16 | — |
— | — | — | |||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||
— |
— |
|||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||
Financial liabilities not measured at fair value |
||||||||||||||||||||||||||||||||||||
Accounts payable and accruals | — | — | — | — | ||||||||||||||||||||||||||||||||
Credit facilities | 13 | — | — | — | — | |||||||||||||||||||||||||||||||
Debentures | 14 | — | — | — | — | |||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||
— |
— |
|||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
26. |
Fair value of financial instruments (Continued from previous page) |
(b) | Accounting classifications and fair values (Continued from previous page) |
Carrying amount |
Fair value |
|||||||||||||||||||||||||||||||||||
December 31, 2020 |
Note |
FVTPL |
Financial asset at amortized cost |
Other financial liabilities |
Total |
Level 1 |
Level 2 |
Level 3 |
Total |
|||||||||||||||||||||||||||
Financial assets measured at fair value |
||||||||||||||||||||||||||||||||||||
Investment portfolio |
— | — | — | |||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||
— | — | |||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||
Financial assets not measured at fair value |
||||||||||||||||||||||||||||||||||||
Cash and cash equivalent |
— | — | — | — | ||||||||||||||||||||||||||||||||
Loans receivable – current |
4 | — | — | — | — | |||||||||||||||||||||||||||||||
Loans receivable – non-current |
4 | — | — | — | — | |||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||
— | — | |||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||
Financial liabilities not measured at fair value |
||||||||||||||||||||||||||||||||||||
Accounts payable, accruals and other |
— | — | — | — | ||||||||||||||||||||||||||||||||
Credit facilities |
9 | — | — | — | — | |||||||||||||||||||||||||||||||
Debentures |
10 | — | — | — | — | |||||||||||||||||||||||||||||||
Convertible debentures |
11 | — | — | — | — | |||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||
— |
— |
|||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
(c) | Measurement of fair values |
(i) | Valuation techniques and significant unobservable inputs |
|
26. |
Fair value of financial instruments (Continued from previous page) |
(c) | Measurement of fair values (Continued from previous page) |
(i) | Valuation techniques and significant unobservable inputs (Continued from previous page) |
Type |
Valuation technique |
Significant unobservable inputs |
Inter-relationship between significant unobservable inputs and fair value | |||
Investment portfolio: |
||||||
Equities - Unlisted |
• Price of recent investments in the investee company • Implied multiples from recent transactions of the underlying investee companies • Offers received by investee companies • Revenue multiples derived from comparable public companies and transactions • Option pricing model |
• Third-party transactions • Revenue multiples • Balance sheets and last twelve-month revenues for certain of the investee companies • Equity volatility • Time to exit events |
• Increases in revenue multiples increases fair value • Increases in equity volatility can increase or decrease fair value depending on class of shares held in the investee company • Increases in estimated time to exit event can increase or decrease fair value depending on class of shares held in the investee company | |||
Partnership interest and others |
• Adjusted net book value |
• Net asset value per unit • Change in market pricing of comparable companies of the underlying investments made by the partnership |
• Increases in net asset value per unit or change in market pricing of comparable companies of the underlying investment made by the partnership can increase fair value | |||
Loan receivable – non-current |
• Discounted cash flows: Considering expected prepayments and using management’s best estimate of average market interest rates with similar remaining terms. |
• Expected timing of cash flows • Discount rate 12% |
• Changes to the expected amount and timing of cash flow changes fair value • Increases to the discount rate can decrease fair value | |||
Derivative financial assets |
• Option pricing model |
• Equity stock price and volatility |
• Increase in equity stock price and volatility will increase fair value |
26. |
Fair value of financial instruments (Continued from previous page) |
(c) |
Measurement of fair values (Continued from previous page) |
(i) |
Valuation techniques and significant unobservable inputs (Continued from previous page) |
December 31, 2021 |
December 31, 2020 |
|||||||
Balance of Level 3 investments, opening |
||||||||
Additions |
||||||||
Disposal |
( |
) | — | |||||
Unrealized exchange loss |
( |
) |
( |
) | ||||
Realized gain on investment portfolio |
— | |||||||
Unrealized gain (loss) on investment portfolio |
( |
) |
( |
) | ||||
Balance of level 3 investments, end of period |
||||||||
(ii) |
Sensitivity analysis |
Profit or loss |
||||||||||
Increase |
Decrease |
|||||||||
Investment portfolio: |
||||||||||
December 31, 2021 |
Adjusted market multiple (5% movement) | ( |
) | |||||||
December 31, 2020 |
Adjusted market multiple (5% movement) | ( |
) |
27. |
Nature and extent of risk arising from financial instruments |
27. |
Nature and extent of risk arising from financial instruments (Continued from previous page) |
($000s) |
2022 |
2023 |
2024 |
2025 |
2026 |
Thereafter |
||||||||||||||||||
Commitments - operational |
||||||||||||||||||||||||
Lease payments |
||||||||||||||||||||||||
Trade payables |
— | — | — | — | — | |||||||||||||||||||
Accrued wages and other expenses |
— | — | — | — | — | |||||||||||||||||||
Interest – Credit facilities (Note 13) |
— | — | ||||||||||||||||||||||
Interest – Debentures (Note 14) |
— | — | — | |||||||||||||||||||||
Purchase obligations |
— | — | — | — | — | |||||||||||||||||||
Commitments – principal repayments |
||||||||||||||||||||||||
Credit facility (Note 13) |
— | — | — | — | — | |||||||||||||||||||
Debentures (Note 14) |
— | — | — | |||||||||||||||||||||
— | — | |||||||||||||||||||||||
Total contractual obligations |
||||||||||||||||||||||||
27. |
Nature and extent of risk arising from financial instruments (Continued from previous page) |
(‘$000 in US$) |
December 31, 2021 |
December 31, 2020 |
||||||
Cash |
||||||||
Investment portfolio |
||||||||
Derivative financial liabilities |
( |
) | — | |||||
Debentures |
( |
) | ( |
) | ||||
28. |
Equity |
(a) |
Share capital |
28. |
Equity (Continued from previous page) |
(b) | Treasury share reserve |
(c) | Options |
Options Outstanding (000s) |
Weighted Average Grant Date Fair Value $ |
Weighted Average Exercise Price $ |
Options Exercisable (000s) |
Weighted Average Exercise Price $ |
||||||||||||||||
Balance, December 31, 2019 |
— | |||||||||||||||||||
Options granted |
— | — | ||||||||||||||||||
Exercised |
( |
) | — | — | — | |||||||||||||||
Forfeited |
( |
) | — | — | — | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance, December 31, 2020 |
— | |||||||||||||||||||
Options granted |
— | — | ||||||||||||||||||
Exercised |
( |
) | — | — | — | |||||||||||||||
Forfeited |
( |
) | — | — | — | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance, December 31, 2021 |
— | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
28. |
Equity (Continued from previous page) |
(c) |
Options (Continued from previous page) |
For the year ended December 31, 2021 |
For the year ended December 31, 2020 |
|||||||
Risk-free interest rate |
||||||||
Expected life |
||||||||
Expected volatility in market price of shares |
||||||||
Expected dividend yield |
||||||||
Expected forfeiture rate |
||||||||
28. |
Equity (Continued from previous page) |
(d) | Restricted share units |
Number of RSUs (000s) |
||||
Balance, December 31, 2019 |
||||
Converted |
( |
) | ||
Expired |
( |
) | ||
Balance, December 31, 2020 |
||||
Converted |
( |
) | ||
Expired |
( |
) | ||
Balance, December 31, 2021 |
||||
(e) | Warrants |
Warrants Outstanding (000s) |
Weighted Average Exercise Price $ |
Warrants Exercisable (000s) |
Weighted Average Exercise Price $ |
|||||||||||||
Balance, December 31, 2019 |
||||||||||||||||
Warrants granted |
— | — | ||||||||||||||
Warrants exercised |
( |
) | — | — | ||||||||||||
Balance, December 31, 2020 |
||||||||||||||||
Warrants granted |
— | — | ||||||||||||||
Warrants exercised |
( |
) | — | — | ||||||||||||
Balance, December 31, 2021 |
||||||||||||||||
28. |
Equity (Continued from previous page) |
(e) |
Warrants (Continued from previous page) |
For the year ended December 31, 2021 |
For the year ended December 31, 2020 |
|||||||
Risk-free interest rate |
||||||||
Expected life |
||||||||
Expected volatility in market price of shares |
||||||||
Expected dividend yield |
||||||||
Expected forfeiture rate |
||||||||
29. |
Cash flow changes from financing activities |
Non-cash changes |
||||||||||||||||||||||||
January 1, 2021 |
Cash flows |
Conversion/ Other |
Foreign exchange |
Fair Value/ Amortization |
December 31, 2021 |
|||||||||||||||||||
Share capital |
— |
— |
||||||||||||||||||||||
Lease liability |
( |
) |
— |
— |
||||||||||||||||||||
Credit facility |
— |
— |
— |
|||||||||||||||||||||
Debentures |
( |
) |
( |
) |
( |
) |
||||||||||||||||||
Convertible debentures |
— |
( |
) |
— |
— |
— |
||||||||||||||||||
Total |
( 1 4 |
) |
||||||||||||||||||||||
Non-cash changes |
||||||||||||||||||||||||
January 1, 2020 |
Cash flows |
Conversion/ Other |
Foreign exchange |
Fair Value/ Amortization |
December 31, 2020 |
|||||||||||||||||||
Share capital |
— | — | ||||||||||||||||||||||
Lease liability |
( |
) | ( |
) | — | — | ||||||||||||||||||
Credit facility |
( |
) | — | — | ||||||||||||||||||||
Debentures |
( |
) | ( |
) | ( |
) | ||||||||||||||||||
Convertible debentures |
— | ( |
) | — | ||||||||||||||||||||
Total |
( |
) | ( |
) | ||||||||||||||||||||